证券代码：300513 证券简称：恒实科技 公告编号：2025-021 特此公告。 北京恒泰实达科技股份有限公司 董事会 2025 年 5 月 29 日 北京恒泰实达科技股份有限公司 关于聘任财务负责人的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 北京恒泰实达科技股份有限公司（以下简称"公司"）目前由董事长、总经 理钱苏晋先生代行财务负责人职责。公司于 2025 年 5 月 29 日召开第三届董事会 第六十二次会议，审议通过了《关于聘任公司财务负责人的议案》。经公司董事 长、总经理钱苏晋先生提名，董事会同意聘任朱义章先生（简历附后）为公司财 务负责人，任期自公司董事会审议通过之日起至第三届董事会届满时止，同时钱 苏晋先生不再代行公司财务负责人职责。 附：候选人简历 朱义章先生，1981年出生，中国国籍，无境外永久居留权，本科学历，持有 注册会计师、注册税务师证书。历任信永中和会计师事务所（特殊普通合伙）项 目经理、安永华明会计师事务所（特殊普通合伙）审计经理、道有道科技集团股 份公司财务总监兼信息披露负责人、北京趣拿信息技术有限公司（去哪儿网）财 务 ...

证券代码：300513 证券简称：恒实科技 公告编号：2025-020 北京恒泰实达科技股份有限公司 第三届董事会第六十二次会议决议公告 本公司及董事会全体成员保证信息披露内容的真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 一、董事会会议召开情况 1、本次董事会会议通知于 2025 年 5 月 26 日以电话、邮件方式发出。 4、本次会议由董事长钱苏晋先生主持，公司董事会秘书、监事及高级管理 人员列席了本次会议。 5、本次董事会会议的召开符合有关法律、行政法规、部门规章、规范性文 件和公司章程的规定，合法有效。 二、 董事会会议审议情况 1、审议通过《关于聘任公司财务负责人的议案》 公司目前由董事长、总经理钱苏晋先生代行财务负责人职责。经钱苏晋先生 提名，董事会拟聘任朱义章先生为公司财务负责人，任期自公司董事会审议通过 之日起至第三届董事会届满时止。本议案已经公司董事会审计委员会和提名委员 会审议通过。 具体内容详见同日公司在巨潮资讯网披露的《关于聘任财务负责人的公告》。 表决情况：同意8票；反对0票；弃权0票。 表决结果：通过。 2、审议通过《关于制订<货币资金管理制度>的议案》 2、本次董事会 ...

铭达律师事务所 法律意见书 北京市铭达律师事务所 关于北京恒泰实达科技股份有限公司 2024 年年度股东大会的 法 律 意 见 书 铭达律师事务所 MINGDA LAW FIRM 北京市铭达律师事务所（以下简称"本所"）接受北京恒泰实达科技股份有限 公司（以下简称"公司"）的委托，就公司召开2024年年度股东大会（以下简称"本 次股东大会"）的有关事宜，根据《中华人民共和国公司法》（以下简称"《公司 法》"）、《中华人民共和国证券法》（以下简称"《证券法》"）、《上市公司股 东大会规则》等法律、法规、规范性文件以及《北京恒泰实达科技股份有限公司 章程》（简称"《公司章程》"）的有关规定，出具本法律意见书。 为出具本法律意见书，本所律师对本次股东大会所涉及的有关事项进行了必 要的核查，审查了本所律师认为出具本法律意见书所需审查的相关文件。本所律 师依据法律意见书出具日前已经发生或存在的事实及本所律师对我国现行法律、 法规及规范性文件的理解发表法律意见。 在本法律意见书中，本所律师仅对法律意见书结论意见中涉及的事项发表法 律意见，并不对本次股东大会所审议议案的具体内容以及该等议案中的数据或表 述的真实性、准确性、 ...

本公司及董事会全体成员保证信息披露内容的真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 特别提示： 1、本次股东大会无否决议案的情况 证券代码：300513 证券简称：恒实科技 公告编号：2025-019 北京恒泰实达科技股份有限公司 2024年年度股东大会决议公告 2、本次股东大会不涉及变更前次股东大会决议 一、会议召开和出席情况 1、会议召开情况 时间：2025 年 5 月 23 日 14:00 地点：北京市海淀区林风二路39号院1号楼11层会议室。 方式：本次股东大会采取现场投票与网络投票相结合的方式。其中，通过深 圳证券交易所交易系统进行网络投票的具体时间为 2025 年 5 月 23 日上午 9:15 —9:25、9:30—11:30,下午 13:00-15:00；通过深圳证券交易所互联网投票系统 投票的具体时间为：2025 年 5 月 23 日上午 9:15 至下午 15:00 期间的任意时间。 召集人：公司董事会 主持人：钱苏晋先生 本次会议的召开已经公司第三届董事会第六十一次会议审议通过，会议召 集、召开符合有关法律、行政法规、部门规章、规范性文件和公司章程的规定。 2、会议出席情况 ...

Group 1 - Huiyu Pharmaceutical's subsidiary received drug registration certificate for Carboxymethyl Sodium Injection, which is used for treating bleeding diseases in various medical fields [1] - Baihe Co., Ltd. announced a plan for a director to reduce holdings by up to 424,000 shares, representing 0.6625% of the total share capital [1] - Kingood Co., Ltd. received a notification from a global leading automaker for a wheel project, expected to start mass production in 2026 with a lifecycle of 10 years [1][2] Group 2 - Wanhua Chemical plans to repurchase shares worth between 300 million and 500 million yuan, with a maximum repurchase price of 99.36 yuan per share [2] - Warner Pharmaceutical's subsidiary received approval for Acetylcysteine raw material drug, primarily used for treating respiratory diseases [3] - ST Mingcheng plans to publicly transfer 45% equity of its subsidiary, aiming to optimize asset structure [4] Group 3 - Qixia Construction announced a plan to reduce up to 31.5 million shares, accounting for 3% of total share capital [5][6] - Zhejiang Rongtai intends to invest 20 million yuan to establish a wholly-owned subsidiary focused on intelligent robotics [7] - Yuandong Biological received drug registration for Chloral Hydrate Enema, used for sedation and seizure control in children [9] Group 4 - Jiemai Technology's subsidiary signed a strategic cooperation agreement with a solid-state battery company to produce high-safety composite conductive materials [10] - Xianju Pharmaceutical received drug registration for Progesterone Soft Capsules, used for treating functional disorders due to luteal deficiency [11] - Lanhua Kecai's subsidiary reported a temporary production halt, with the resumption date yet to be determined [13] Group 5 - Sinopharm Modern's subsidiary received drug registration for Tocilizumab Tablets, used for treating rheumatoid arthritis and other conditions [15] - Shanghai Bank announced the resignation of its vice president due to organizational adjustments [17] - Shanghai Pharmaceutical's Ephedrine Injection passed the consistency evaluation for generic drugs [19] Group 6 - Rundu Co., Ltd. received drug registration for Amlodipine and Olmesartan Tablets, aimed at treating hypertension [21] - Zhong'an Technology announced that 61 million shares held by its controlling shareholder will be auctioned [23] - Shanghai Washba plans to purchase patent assets and establish two subsidiaries focused on hydrogen energy and solid-state battery technologies [25] Group 7 - Nuo Cheng Jianhua's new drug Tafasitamab received approval for treating relapsed/refractory diffuse large B-cell lymphoma [26] - Benli Technology plans to use up to 200 million yuan of idle funds for cash management and financial investments [28] - Taiji Co., Ltd. intends to use 60 million yuan of idle funds to purchase financial products [29] Group 8 - Haishi Co. announced that its innovative drug Anreke Fen Injection received drug registration for treating postoperative pain [32] - Yulong Co. will have its stock delisted on May 27, 2025, following a decision by the Shanghai Stock Exchange [36] - Weifu High-Tech plans to establish a joint venture with Shanghai Baolong Automotive Technology [38] Group 9 - Xichang Electric Power expects a net profit reduction of approximately 5.4 million yuan due to adjustments in the time-of-use electricity pricing mechanism [39] - Alter signed a contract worth 6.8 billion yen for the development and procurement of large truck EV kits [41] - Zhonglian Heavy Industry plans to acquire controlling stakes in its financing leasing subsidiary through public bidding [42] Group 10 - Sanyou Medical's executive plans to reduce holdings by up to 1.44% of the company's shares [43] - Hangyang Co. plans to establish a subsidiary for large modular cryogenic equipment manufacturing with an estimated investment of 557 million yuan [44] - FAW Fuwi received a notification for a dashboard project from a well-known new energy brand, with total sales expected to reach 1.06 billion yuan [45]

Group 1 - The People's Bank of China emphasizes the implementation of a moderately loose monetary policy to meet the financing needs of the real economy and support key areas such as technological innovation and consumption [2] - The Ministry of Finance reports that from January to April, the national general public budget revenue reached 80,616 billion yuan, a year-on-year decrease of 0.4%, with the decline narrowing by 0.7 percentage points compared to the first quarter [3] - In April, tax revenue increased by 1.9% year-on-year, marking the first month of positive growth this year, while the total tax revenue from January to April was 65,556 billion yuan, down 2.1% year-on-year [4] Group 2 - The Ministry of Finance announces that the securities transaction stamp duty for January to April was 53.5 billion yuan, a year-on-year increase of 57.8% [5] - The National Energy Administration reports that the total electricity consumption in April was 7,721 billion kilowatt-hours, a year-on-year increase of 4.7% [6] - The National Development and Reform Commission states that most policies aimed at stabilizing employment and the economy are expected to be implemented by the end of June [8] Group 3 - The National Development and Reform Commission highlights the need to address "involution" competition that distorts market mechanisms and disrupts fair competition [9] - The China Automobile Industry Association reports that the top ten car manufacturers sold 2.502 million vehicles from January to April, accounting for 68.7% of total car sales [10] - A joint document from the Central Cyberspace Affairs Commission, the National Development and Reform Commission, and the Ministry of Industry and Information Technology outlines goals for IPv6 deployment by 2025, including reaching 850 million active users [11] Group 4 - Various companies are making significant moves, such as Zhaoyi Innovation planning to issue H-shares and list on the Hong Kong Stock Exchange, and several companies announcing share repurchase plans [13] - The Ministry of Finance reports that the total assets and loan growth rates of state-owned banks have slightly declined compared to 2024, but remain relatively high [14] - Zhongtai Securities discusses the logic behind the recent rise in bank stocks, indicating a strong rationale for continued investment in this sector [15]

Group 1 - Zhaoyi Innovation plans to issue H-shares and list on the Hong Kong Stock Exchange, considering the interests of existing shareholders and market conditions [3] - ST Zhongdi has decided to abandon the commercial opportunity for the Jiageng Ke Yi City land project, with the controlling shareholder planning to develop the project instead [4] - Xichang Electric Power expects a reduction of approximately 5.4 million yuan in net profit for 2025 due to adjustments in the time-of-use electricity pricing mechanism [5] Group 2 - Sanfu New Materials intends to invest 620 million yuan in a project for high-safety dry electrode battery key materials and high-frequency electronic information composite materials [6] - Weifu High-Tech's subsidiary plans to establish a joint venture with Baolong Technology to expand the active suspension motor hydraulic pump business [7] - Yulong Co., Ltd. will have its stock delisted on May 27, 2025, following a decision by the Shanghai Stock Exchange [8] Group 3 - Chen'an Technology's shareholder is transferring 6.27% of the company's shares to Hefei Guotou, aiming to introduce strategic investors [9] - Huamao Technology is planning to acquire a 100% stake in Fuchuang Youyue, with stock trading suspended for up to 10 trading days [11] - Baolong Technology's subsidiary will collaborate with Weifu High-Tech's subsidiary to develop core components for the active suspension system [12] Group 4 - Zhongnong Lihua intends to acquire at least 50% of Taizhou Agricultural Supplies, enhancing its product and service range [13] - Weiling Co., Ltd.'s subsidiary has successfully acquired 74.3% of Jiayu Mining for 220 million yuan, focusing on expanding into the non-ferrous metal resource sector [14][15] - Hengshi Technology's subsidiary has been approved for public transfer of shares on the New Third Board [16] Group 5 - Xiang Teng New Materials plans to acquire an additional 12.5% stake in its subsidiary Shanghai Shangda for 25.3 million yuan [17] - ST Texin has extended its employee stock ownership plan by 12 months, reflecting confidence in the company's long-term development [18] - Baili Electric has issued a risk warning regarding its stock price increase, indicating no significant changes in fundamentals [19] Group 6 - Hu Silicon Industry plans to acquire minority stakes in three semiconductor companies for approximately 7.04 billion yuan [20][21] - Demais plans to change its controlling shareholder, leading to a temporary suspension of stock trading [22] - FAW Fuwei has received a notice from a well-known new energy brand for a project expected to generate 1.06 billion yuan in total sales over its lifecycle [23] Group 7 - Hangyang Co. plans to establish a subsidiary for a large modular cryogenic equipment manufacturing project with an estimated investment of 557 million yuan [24] - Jiewate intends to acquire 40.89% of Tianyi Hexin for 319 million yuan, enhancing its product line in the signal chain category [25] - Dingxin Communications has elected a new chairman following the resignation of the previous chairman [26][27] Group 8 - Aofei Entertainment plans to invest 10 million yuan in a partnership to indirectly invest in AI robotics company Xuan Yuan Technology [28] - Huaxi Energy's controlling shareholder has been detained, but the company states that operations remain normal [29] - Yihe Jiaye will change its stock name to "Ruimaite" starting May 21 [30] Group 9 - Zhongjin Environment will change its name to "Southern Pump Industry" effective May 21 [31] - Hong Sifang's subsidiary plans to invest approximately 1.49 billion yuan in a new chemical materials and fertilizers industrial park [32] - Buchang Pharmaceutical's subsidiary has signed a research agreement for MF59 adjuvant with a pharmaceutical company [33] Group 10 - Hongjing Technology has signed a service contract worth 597 million yuan for a smart computing project [34] - Zhuojin Co. has won a bid for a soil remediation project worth 67.68 million yuan [35] - Xinjiang Jiaojian has been awarded a contract for a highway project valued at 451 million yuan [36] Group 11 - China National Materials Energy's subsidiary has signed a contract for an EPC project in Uzbekistan worth approximately 1.252 billion yuan [37] - Ruixin Microelectronics' shareholder plans to reduce its stake by up to 2% [38] - Shanghai Yizhong's shareholder also plans to reduce its stake by up to 2% [39] Group 12 - Sanyou Medical's controlling shareholder plans to reduce its stake by up to 1.44% [40] - Hangdian Co.'s controlling shareholder plans to reduce its stake by up to 1.93% [41] - Shangwei New Materials' shareholder plans to reduce its stake by up to 3% [42] Group 13 - Mingchen Health plans to repurchase shares worth between 30 million and 50 million yuan [43] - Jiuhua Tourism plans to raise up to 500 million yuan through a private placement for various projects [44] - Yuegui Co. plans to raise up to 900 million yuan for several projects [46]

智通财经5月20日电，恒实科技(300513.SZ)公告称，公司参股公司前景无忧的股票挂牌转让申请已获同 意，将于2025年5月20日起在全国股转系统挂牌公开转让，证券简称为前景无忧，证券代码为874746， 交易方式为集合竞价交易，所属层级为基础层。 恒实科技：参股公司前景无忧正式挂牌新三板 ...

证券代码：300513 证券简称：恒实科技 公告编号：2025-018 北京恒泰实达科技股份有限公司 关于参股公司正式挂牌新三板的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 近日，北京恒泰实达科技股份有限公司（以下简称"恒实科技"或"公司"） 之参股公司北京前景无忧电子科技股份有限公司（以下简称"前景无忧"）股票 挂牌公告转让申请已经全国股转公司审查同意，前景无忧公司股票将于2025年5 月20日起在全国股转系统挂牌公开转让。 前景无忧挂牌信息如下： 交易方式：集合竞价交易 所属层级：基础层 前景无忧的《公开转让说明书》等相关文件已于2025年4月30日披露于全国 中小企业股份转让系统指定信息披露平台www.neeq.com.cn或www.neeq.cc，敬请 投资者查阅。 特此公告。 北京恒泰实达科技股份有限公司 董事会 2025 年 5 月 20 日 证券简称：前景无忧 证券代码：874746 ...

北京恒泰实达科技股份有限公司 投资者关系活动记录表 证券代码：300513 证券简称：恒实科技 | | 3、高管您好，能否请您介绍一下本期行业整体和行业内其他主要 | | | | | | --- | --- | --- | --- | --- | --- | | | 企业的业绩表现？谢谢。 | | | | | | | 答：您好，公司所处行业情况详见公司《2024 年年度报告》第三节 | | | | | | | "管理层讨论与分析"中"一、报告期内公司所处行业情况"，行 | | | | | | | 业内其他企业的业绩请查阅相关公司披露的财务信息。感谢您的关 | | | | | | | 注。 | | | | | | | 4、高管您好，请问您如何看待行业未来的发展前景？谢谢。 | | | | | | | 答：您好，随着信息技术的发展，预计软件和信息技术服务行业将 | | | | | | | 会发展出更多的新兴技术及创新应用模式，为企业在技术革新的发 | | | | | | | 展中赋能。感谢您的关注。 | | | | | | 附件清单（如有） | 无 | | | | | | 日期 | 2025 5 | 年 | 月 ...